Carlos Borge
Child & Adolescent Psychiatry · Sarasota, FLNPI 1881715316
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 33.6% of the total. Reporting peaked in 2019 at $10,507 and has fallen 89.7% since, to $1,082 in 2025. Among child & adolescent psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $164.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$5K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- AbbVie$736
- Johnson & Johnson$734
- Neurocrine Biosciences, Inc.$694
- Axsome Therapeutics, Inc.$589
- plus $3K from 12 others
What the payments were for
- Speaking & faculty fees$7,20049%
- Travel & lodging$1,42710%
- Food & beverage$5,83840%
- Education$1651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 25 | $4,919 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $4,428 |
| AbbVie(2 entities) | 13 | $736 |
| Johnson & Johnson | 6 | $734 |
| Neurocrine Biosciences, Inc. | 6 | $694 |
| Axsome Therapeutics, Inc. | 5 | $589 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $416 |
| Jazz Pharmaceuticals Inc. | 3 | $342 |
| Teva Pharmaceuticals USA, Inc. | 3 | $326 |
| Alkermes, Inc. | 3 | $318 |
| Supernus Pharmaceuticals, Inc. | 6 | $276 |
| Sunovion Pharmaceuticals Inc. | 4 | $250 |
| Otsuka America Pharmaceutical, Inc. | 2 | $200 |
| E.r. Squibb & Sons, L.L.C. | 2 | $152 |
| Tris Pharma Inc | 1 | $112 |
| TMS Neurohealth Centers Inc. | 1 | $102 |
| Noven Therapeutics, LLC | 1 | $21 |
| Neos Therapeutics, LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINTELLIX$4,428
- Jornay PM 20mg capsules (Bottle of 100)$4,363
- SPRAVATO$734
- INGREZZA$598
- Auvelity$589
- LYBALVI$500
- VRAYLAR$470
- CAPLYTA$369
- QELBREE$248
- AUSTEDO$235
- XYWAV$230
- LATUDA$226
- COBENFY$125
- Dyanavel XR$112
- XYREM$112
- REXULTI$108
- TMS NeuroHealth Centers Inc.$102
How this compares
$14,631 in reported general payments places this provider in the 95th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 17 | $23,199 |
| TrintellixVortioxetine Hydrobromide | 23 | $10,732 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 167 | $8,698 |
| Olanzapine-Fluoxetine HclOlanzapine/Fluoxetine Hcl | 25 | $7,797 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 169 | $6,703 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 83 | $4,923 |
| Lisdexamfetamine Dimesylate | 15 | $4,831 |
| Clonazepam | 395 | $4,031 |
| Paliperidone ErPaliperidone | 12 | $3,519 |
| Aripiprazole | 112 | $2,921 |
| Gabapentin | 123 | $2,499 |
| Alprazolam | 218 | $2,381 |
| Lurasidone Hcl | 15 | $2,099 |
| Clorazepate Dipotassium | 13 | $1,963 |
| Lamotrigine | 171 | $1,824 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $736 | $23,19917 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $4,428 | $10,73223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 206 child & adolescent psychiatry providers in Florida.
Other child & adolescent psychiatry in Sarasota
- Craig KuninsGulfport$265K
- Elias SarkisGainesville$169K
- Jeffrey AlvaroSt Petersburg$87K
- Rosa Negron MunozLakeland$39K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Justin SpoonerPonte Vedra Beach$12K
- Bhaskar RajuOrlando$11K
- Americo PadillaMiami$11K
- Marcos CintronHialeah$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.